SEC Form 4 · accession 0000921895-16-004737
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
May 26, 2016
Accepted (ET)
May 31, 2016 · 6:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 26, 2016 | S | 27,168 | $1.92 | D | 5,389,745 | D | |
| Common Stock | May 26, 2016 | S | 12,700 | $1.93 | D | 5,377,045 | D | |
| Common Stock | May 26, 2016 | S | 200 | $1.935 | D | 5,376,845 | D |
Table II — derivative securities
No Table II lines on this filing.